Clinical relevance of loss of heterozygosity of the short arm of chromosome 1 in neuroblastoma: A single-institution study

International Journal of Cancer

Volumn 69, Issue 2, 1996, Pages 73-78

  Schleiermacher, Gudrun ^a   Delattre, Olivier ^a   Peter, Martine ^a   Mosseri, Véronique ^a   Delonlay, Pascale ^a   Vielh, Philippe ^a   Thomas, Gilles ^a   Zucker, Jean Michel ^a   Magdelénat, Henri ^b   Michon, Jean ^a  

^a INSTITUT CURIE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CHROMOSOME 1P; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY LOSS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; ONCOGENE C MYB; PRIORITY JOURNAL; PROGNOSIS;

CHROMOSOMES, HUMAN, PAIR 1; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENES, MYC; HUMANS; INFANT; MALE; NEUROBLASTOMA; PROGNOSIS; SEQUENCE DELETION; SURVIVAL ANALYSIS;

EID: 15844379315     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960422)69:2<73::AID-IJC1>3.0.CO;2-S     Document Type: Article

References (22)

1. AMBROS, P.F. and 13 OTHERS, Regression and progression in neuroblastomas. Does genetics predict tumor behaviour? Europ. J. Cancer. 31A, 510-515(1995).
2. BERTHOLD, F., KASSENBÖHMER, R, and ZIESCHANG, J., Multivariate evaluation of prognostic factors in localized neuroblastoma. Amer. J. ped. Hematol. Oncol., 16, 107-115 (1994).
3. BRODEUR, G.M. and CASTLEBERRY, R.P., Neuroblastoma. In: P.A. Pizzo and D.G. Poplack (eds.), Principle and practice of pediatric oncology, pp. 739-767, Lippincott, Philadelphia (1993).
4. BRODEUR, G.M., SEEGER, R.C., SCHWAB, M., VARMUS, H.E. and BISHOP. J.M., Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (Wash.), 224, 1121-1124 (1984).
5. BRODEUR, G.M., SEKHON, G. and GOLDSTEIN, M.N., Chromosomal aberrations in human neuroblastoma. Cancer, 40, 2256-2263 (1977).
6. BRODEUR, G.M., and 21 OTHERS, Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment, J clin. Oncol., 11, 1466-1477 (1993).
7. CARON, H. and 12 OTHERS, Evidence for 2 tumor suppressor loci on chromosome bands 1p35-36 in neuroblastoma: one probably inprinted, another associated with N-myc amplification. Hum. mol. Genet., 4, 535-539 (1995).
8. CHRISTIANSEN, H. and LAMPERT, F., Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Brit. J Cancer, 57,121-126 (1988).
9. FONG, C.T., DRACOPOLI, N.C., WHITE, P.S., MERRILL, P.T., GRIFFITH, R.C., HOUSMAN, D.E. and BRODEUR, G.M., Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification, Proc. nat. Acad. Sci (Wash.), 86, 3753-3757 (1989).
10. FONG, C.T., WHITE, P.S., PETERSON, K., SAPIENZA, C., CAVENEE, W.K., KERN. S., VOGELSTEIN, B., CANTOR, A.B., LOOK, A.T. and BRODEUR, G.M., Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res., 52, 1780-1785 (1992).
11. GRAHAM-POLE, J., SALMI, T., ANTON, A.H., ABRAMOWSKY, C. and GROSS, S., Tumor and urine catecholamines (CATs) in neurogenic tumors. Correlations with other prognostic factors and survival. Cancer, 51, 834-839 (1983).
12. HAYASHI, Y., KANDA, N., INABA, T., HANADA, R., NAGAHARA, N., MUCHI, H. and YAMAMOTO, K., Cytogenetic findings and prognosis in neurobiastoma with emphasis on marker chromosome 1. Cancer, 63, 126-132 (1989).
13. LABROSSE, E.H., COM-NOUGUÉ, C., ZUCKER, J.M., COMOY, E., BoHUON, C., LEMERLE, J. and SCHWEISGUTH, O., Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors. Cancer Res., 40, 1995-2001 (1980).
14. LOOK, A.T., HAYES, A., SHUSTER, J.J., DOUGLASS, E.C., CASTLEBERRY, R.P., BOWMAN, L.C., SMITH, E.I. and BRODEUR, G.M., Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study, J. clin. Oncol. 9, 581-591 (1991).
15. MICHON, J., DELATTRE, O., ZUCKER, J.M., PETER, M., DELONLAY, P., LUCIANI, S., MOSSERI, V., VIELH, P., NEUENSCHWANDER, S. and THOMAS, G., Prospective evaluation of N-myc amplification and deletion of the short arm of chromosome 1 in neuroblastoma tumors: a single-institution study. In A.E. Evans, J.L. Biedler. G.M. Brodeur. G.J- D'Angio and A. Nakagawara (eds.), Advances in neuroblastoma research, Vol. 4, pp. 11-17, Wiley-Liss. New York (1994).
16. PETER, M., MICHON, J., VIELH, P., NEUENSCHWANDER, S., NAKAMURA. Y., SONSINO, E., ZUCKER, J.M., VERGNAUD, G., THOMAS, G. and DELATTRE, O., PCR assay for chromosome 1p deletion in small neuroblastoma samples. Int. J. Cancer, 52, 544-548 (1992).
17. SCHLEIERMACHER, G., PETER, M., MICHON, J., HUGOT, J.P., VIELH, P., ZUCKER, J.M., MAGDELÉNAT, H., THOMAS, G. and DELATTRE, O., Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chrom Cancer, 10, 275-281 (1994).
18. SCHWAB, M., ALITALO, K., KLEMPNAUER, K.H., VARMUS, H.E., BISHOP, J.M., GILBERT, F., BRODEUR, G., GOLDSTEIN, M. and TRENT, J., Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature (Lond.), 305, 245-248 (1983).
19. SEEGER, R.C., BRODEUR, G.M., SATHER, H., DALTON, A., SIEGEL, S.E., WONG, K.Y. and HAMMOND, D., Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. New Engl. J. Med., 313, 1111-1116 (1985).
20. TAKEDA, O., HOMMA, C., MASEKI, N., SAKURAI, M., KANDA, N., SCHWAB, M., NAKAMURA, Y. and KANEKO, Y., There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chrom. Cancer, 10, 30-39 (1994).
21. WETH, A., MARTINSSON, T., CZIEPLUCH, C., BRÜDERLEIN, S., AMLER, L.C., BERTHOLD, F. and SCHWAB. M., Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chrom, Cancer, 1, 159-166 (1989).
22. ZUCKER, J.M. and 13 OTHERS, Single or double consolidation treatment according to remission status after initial therapy in metastatic neuroblastoma. first results of LMCE 3 study in 40 patients. In: A.E. Evans and G.J. D'Angio (eds.), Advances in neuroblastoma research, Vol. 3, pp. 405-425. Wiley-Liss, New York (1991).